期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胱抑素C、颈动脉内膜中层厚度与冠心病的关系 被引量：1

Cystatin C and IMT in patients with coronary heart disease
原文传递
导出
摘要 以往研究认为，血清胱抑素C（CysC）水平是评价肾小球滤过率的敏感指标，近年发现，CysC参与动脉粥样硬化、心肌梗死等心血管疾病的病理过程。颈动脉内膜中层厚度（IMT）与动脉粥样硬化进展、冠状动脉（冠脉）粥样硬化程度及心血管事件相关。因此，本研究旨在探讨CysC、IMT与冠心病冠脉病变的相关程度。 Summary This study investigated the predictabi[ityh of serum cystatin C level （CysC） and intima-media thickness （IMT） of the common carotid artery in patients with coronary artery disease. CysC and IMT in coronary heart disease group were significantly higher than in control group （P〈0.05）. CysC level in AMI group is lower than in SAP group and UAP group while IMT in the AMI group is higher than them （P^0.05）. Therefore, CysC and IMT were closely related to the degree of coronary lesions.
作者 黄冠华 孙刚 闫旭龙
机构地区 包头医学院第二附属医院心内科
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第7期547-548,共2页 Journal of Clinical Cardiology
关键词 冠心病 胱抑素C 颈动脉内膜中层厚度 coronary heart disease cystatin CI intima-media thickness
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献10

  • 1NEWAN D J, THAKKAR H, EDWARDS R G, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J], Kidney Int , 1995,47: 312-318.
  • 2王洪巨,汤阳,王本芳,邵杉,宣玲,周桂建,刘红军.冠心病患者血清胱抑素C水平与冠状动脉病变的相关性[J].临床心血管病杂志,2011,27(10):729-731. 被引量：39
  • 3程方雄,曾昆,刘青建.冠心病患者血清同型半胱氨酸、高敏C-反应蛋白、胱抑素C水平变化及临床意义[J].临床心血管病杂志,2012,28(1):79-80. 被引量：35
  • 4CHOE J Y, PARK S H, KIM S K. Serm cystatian C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment[J]. J Korean Med Sci,2010,25:42-48.
  • 5KOENIG W, TW ARDELLA D, BRENNER H, et al. Plasma concentration of cystatin c in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate[J]. Clin Chem, 2005,51: 321- 327.
  • 6NOTO D, CEFALU A B, BARBAGALLO C M, et al. Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol,2005,101: 213-217.
  • 7LUC G, BARD J M, LESUEUR C, et al. Plasma cystatin C and development of coronary heart disease: The PRIME Study[J]. Atherosclerosis, 2006,85: 375 - 380.
  • 8PIGNOLI P. TREMOLI E, POLI A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging [J]. Circuation , 1986,74: 1399-1400.
  • 9翟丽华,王沙燕,梁旭,杨纯玉,张阮章,王增英,汤军,胡玉华.氨氯地平逆转颈动脉内中膜增厚作用与血管紧张素转换酶基因型的相关性[J].中华心血管病杂志,2008,36(6):510-513. 被引量：16
  • 10HOLAJ R, SPACIL J, PETRASEK J, et al. Relation of the thickness of the intima and media of the common carotid artery, atherosclerotic plaque in the carotids and manifestations of atherosclerosis in the vessels of t he lower ext remit y in comparison to coronaryatherosclerosis[J]. Cas Lek Cesk , 1998, 137: 716-720.

二级参考文献28

  • 1黄洁,成小如,李卫,丁金凤,康连鸣,汪芳,李一石.氨氯地平剂量对高血压患者肾素-血管紧张素-醛固酮系统的影响[J].中国临床药理学杂志,2005,21(2):100-102. 被引量：2
  • 2杨慧琴,陶黎.单纯收缩期高血压患者脉压与颈动脉粥样硬化相关性分析[J].中国预防医学杂志,2006,7(2):127-129. 被引量：5
  • 3Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion / deletion polymorphism of the human angiotensin comverting enzyme gene (DCP1). Nucleic Acid Res, 1992,20: 1433.
  • 4Rongling LI, Bruce B, Patricia A, et al. B-mode-detected carotid artery plaque in a general population. Stroke, 1994,25: 2377- 2383.
  • 5Prisant LM, Zemel PC, Nichols FT, et al. Carotid plaque associations among hypertensive patients. Arch Intern Med , 1993, 153 : 501-506.
  • 6Pitt B, Byington RP, Furberg CD ,et al. Effect of amlodipine on the protression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation,2000,102 : 1503-1510.
  • 7Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke, 2006, 37 : 1933-1940.
  • 8Zanchetti A, Hennig M, Baurecht H, et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. Hypertens, 2007, 25:2463-2470.
  • 9Pontremoli R, Ravera M, Viazzi F,et al. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. Kidney Int,2000, 57:561-569.
  • 10Kyselovic J, Krenek P, Wibo M, et al. Effects of amlodipine and laci-dipine on cardiac remodeling and rennin production in salt - loaded stroke-prone hypertensive rats. Br J Pharmacol, 2001, 134: 1516-1522.

共引文献83

同被引文献15

  • 1Stein J H, Korcarz C E, Post W S, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:summary and discus- sion of the American society of echocardiography consen- sus statement [J]. Prey Cardiol, 2009, 12( 1 ) :34-38.
  • 2Stein J H, Korcarz C E, Hurst R T, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force [J]. J Am Soc Echo- cardiogr, 2008, 21(2) :93-111.
  • 3Sibal L, Agarwal S C, Home P D. Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes [J]. Diabetes Metab Syndr Obes, 2011, 19 (4) :23-34.
  • 4Rob J, Chang C L, Bhalla A, et al. Interrnedin is a calci- tonin/calcitonin generelated peptide family peptide acting through the calcitonin receptor-like receptor/receptor ac- tivity-modifying protein receptor complexes [ J ]. J Biol Chem, 2004, 279(8):7264-7274.
  • 5Pan C S, Yang J H, Cai D Y, et al. Cardiovascular effects of newly discovered peptide interrnedin/ad- renomedullin 2 [J].Peptides, 2005, 26(9):1640-1646.
  • 6Fujisawa Y, Nagai Y, Miyatake A, et al. Effects of ad- renomedullin 2 on regional hemodynamics in conscious rats [J]. Eur J Pharrnacol, 2007, 558(1-3) :128-132.
  • 7Anastasi A, Brown M A, Kembhavi A A, et al. Cysta-tin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detec- tion in chicken serum [J]. Biochem J, 1983, 211 ( 1 ) : 129-138.
  • 8Kestenbaum B, Rudser K D, de Boer I H, et al. Differ- ences in kidney function and incident hypertension:the multiethnic study of atherosclerosis [ J ]. Ann Intern Med, 2008, 148(7):501-508.
  • 9Luc G, Bard J M, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease:The PRIME Study [ J ]. Atherosclerosis, 2006, 185 (2) :375-380. e estimation of renal function in male gout patients with renal impairment[J]. J Korean Med Sci, 2010, 25(1) :42-48.
  • 10Choe J Y, Park S H, Kim S K. Serum cystatin C is a potential endogenous marker for th.

引证文献1

二级引证文献5

临床心血管病杂志
2013年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部